DNA vaccination efficiently induces antibodies to Nogo-A and does not exacerbate experimental autoimmune encephalomyelitis

European Journal of Pharmacology

Volumn 588, Issue 1, 2008, Pages 99-105

  Bourquin, Carole ^a,b   van der Haar, Marjan E ^c   Anz, David ^b   Sandholzer, Nadja ^b   Neumaier, Irmgard ^d   Endres, Stefan ^b   Skerra, Arne ^d   Schwab, Martin E ^c   Linington, Christopher ^a  

^a MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

DNA vaccination; Immunization; Multiple sclerosis; Myelin; Nogo A

Indexed keywords

MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NOGO A ANTIBODY; PLASMID VECTOR; PROTEIN NOGO A; PROTEOLIPID PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DNA IMMUNIZATION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PATHOGENICITY; PRIORITY JOURNAL; SINGLE DRUG DOSE; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, BLOCKING; BLOTTING, WESTERN; CELLS, CULTURED; CEREBELLUM; CHO CELLS; CRICETINAE; CRICETULUS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; MICE; MYELIN PROTEINS; OLIGODENDROGLIA; PLASMIDS; RATS; VACCINES, DNA;

EID: 44249113802     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.04.026     Document Type: Article

References (49)

1. Attanasio R., Pehler K., and Scinicariello F. DNA-based immunization induces anti-CD4 antibodies directed primarily to native epitopes. FEMS Immunol. Med. Microbiol. 17 (1997) 207-215
2. Bourquin C., Iglesias A., Berger T., Wekerle H., and Linington C. Myelin oligodendrocyte glycoprotein-DNA vaccination induces antibody-mediated autoaggression in experimental autoimmune encephalomyelitis. Eur. J. Immunol. 30 (2000) 3663-3671
3. Bourquin C., Schmidt L., Hornung V., Wurzenberger C., Anz D., Sandholzer N., Schreiber S., Voelkl A., Hartmann G., and Endres S. Immunostimulatory RNA oligonucleotides trigger an antigen-specific cytotoxic T-cell and IgG2a response. Blood 109 (2007) 2953-2960
4. Bourquin C., Schubart A., Tobollik S., Mather I., Ogg S., Liblau R., and Linington C. Selective unresponsiveness to conformational B cell epitopes of the myelin oligodendrocyte glycoprotein in H-2b mice. J. Immunol. 171 (2003) 455-461
5. Boyer J.D., Ugen K.E., Wang B., Agadjanyan M., Gilbert L., Bagarazzi M.L., Chattergoon M., Frost P., Javadian A., Williams W.V., Refaeli Y., Ciccarelli R.B., McCallus D., Coney L., and Weiner D.B. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat. Med. 3 (1997) 526-532
6. Bregman B.S., Kunkel-Bagden E., Schnell L., Dai H.N., Gao D., and Schwab M.E. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature 378 (1995) 498-501
7. Chen M.S., Huber A.B., van der Haar M.E., Frank M., Schnell L., Spillmann A.A., Christ F., and Schwab M.E. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403 (2000) 434-439
8. Domeniconi M., Cao Z., Spencer T., Sivasankaran R., Wang K., Nikulina E., Kimura N., Cai H., Deng K., Gao Y., He Z., and Filbin M. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron 35 (2002) 283-290
9. Drew D.R., Lightowlers M., and Strugnell R.A. Humoral immune responses to DNA vaccines expressing secreted, membrane bound and non-secreted forms of the Tania ovis 45 W antigen. Vaccine 18 (2000) 2522-2532
10. Fiedler M., Horn C., Bandtlow C., Schwab M.E., and Skerra A. An engineered IN-1 F(ab) fragment with improved affinity for the Nogo-A axonal growth inhibitor permits immunochemical detection and shows enhanced neutralizing activity. Protein Eng. 15 (2002) 931-941
11. Fontoura P., and Steinman L. Nogo in multiple sclerosis: growing roles of a growth inhibitor. J. Neurol. Sci. 245 (2006) 201-210
12. Frank M., van der Haar M.E., Schaeren-Wiemers N., and Schwab M.E. rMAL is a glycosphingolipid-associated protein of myelin and apical membranes of epithelial cells in kidney and stomach. J. Neurosci. 18 (1998) 4901-4913
13. Freund P., Schmidlin E., Wannier T., Bloch J., Mir A., Schwab M.E., and Rouiller E.M. Nogo-A-specific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates. Nat. Med. 12 (2006) 790-792
14. Genain C.P., Cannella B., Hauser S.L., and Raine C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5 (1999) 170-175
15. GrandPre T., Nakamura F., Vartanian T., and Strittmatter S.M. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 403 (2000) 439-444
16. Hauben E., Butovsky O., Nevo U., Yoles E., Moalem G., Agranov E., Mor F., Leibowitz-Amit R., Pevsner E., Akselrod S., Neeman M., Cohen I.R., and Schwartz M. Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J. Neurosci. 20 (2000) 6421-6430
17. Hauben E., Ibarra A., Mizrahi T., Barouch R., Agranov E., and Schwartz M. Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 15173-15178
18. Hays A.P., Latov N., Takatsu M., and Sherman W.H. Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein. Neurology 37 (1987) 242-256
19. Heckelsmiller K., Beck S., Rall K., Sipos B., Schlamp A., Tuma E., Rothenfusser S., Endres S., and Hartmann G. Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapy. Eur. J. Immunol. 32 (2002) 3235-3245
20. Inchauspe G., Vitvitski L., Major M.E., Jung G., Spengler U., Maisonnas M., and Trepo C. Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization. DNA Cell. Biol. 16 (1997) 185-195
21. Jurewicz A., Matysiak M., Raine C.S., and Selmaj K. Soluble Nogo-A, an inhibitor of axonal regeneration, as a biomarker for multiple sclerosis. Neurology 68 (2007) 283-287
22. Karnezis T., Mandemakers W., McQualter J.L., Zheng B., Ho P.P., Jordan K.A., Murray B.M., Barres B., Tessier-Lavigne M., and Bernard C.C. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination. Nat. Neurosci. 7 (2004) 736-744
23. Kerlero de Rosbo N., Honegger P., Lassmann H., and Matthieu J.M. Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin/oligodendrocyte glycoprotein. J. Neurochem. 55 (1990) 583-587
24. Lewis P.J., van Drunen Littel-van den H., and Babiuk L.A. Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response. J. Virol. 73 (1999) 10214-10223
25. Linington C., Bradl M., Lassmann H., Brunner C., and Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am. J. Pathol. 130 (1988) 443-454
26. Litzenburger T., Bluthmann H., Morales P., Pham-Dinh D., Dautigny A., Wekerle H., and Iglesias A. Development of myelin oligodendrocyte glycoprotein autoreactive transgenic B lymphocytes: receptor editing in vivo after encounter of a self-antigen distinct from myelin oligodendrocyte glycoprotein. J. Immunol. 165 (2000) 5360-5366
27. Lobell A., Weissert R., Eltayeb S., de Graaf K.L., Wefer J., Storch M.K., Lassmann H., Wigzell H., and Olsson T. Suppressive DNA vaccination in myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis involves a T1-biased immune response. J. Immunol. 170 (2003) 1806-1813
28. Lobell A., Weissert R., Storch M.K., Svanholm C., de Graaf K.L., Lassmann H., Andersson R., Olsson T., and Wigzell H. Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis. J. Exp. Med. 187 (1998) 1543-1548
29. Lodmell D.L., Ray N.B., Parnell M.J., Ewalt L.C., Hanlon C.A., Shaddock J.H., Sanderlin D.S., and Rupprecht C.E. DNA immunization protects nonhuman primates against rabies virus. Nat. Med. 4 (1998) 949-952
30. Merkler D., Metz G.A., Raineteau O., Dietz V., Schwab M.E., and Fouad K. Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. J. Neurosci. 21 (2001) 3665-3673
31. Merkler D., Oertle T., Buss A., Pinschewer D.D., Schnell L., Bareyre F.M., Kerschensteiner M., Buddeberg B.S., and Schwab M.E. Rapid induction of autoantibodies against Nogo-A and MOG in the absence of an encephalitogenic T cell response: implication for immunotherapeutic approaches in neurological diseases. Faseb J. 17 (2003) 2275-2277
32. Mukhopadhyay G., Doherty P., Walsh F.S., Crocker P.R., and Filbin M.T. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron 13 (1994) 757-767
33. Oertle T., van der Haar M.E., Bandtlow C.E., Robeva A., Burfeind P., Buss A., Huber A.B., Simonen M., Schnell L., Brosamle C., Kaupmann K., Vallon R., and Schwab M.E. Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J. Neurosci. 23 (2003) 5393-5406
34. Piddlesden S.J., Lassmann H., Zimprich F., Morgan B.P., and Linington C. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am. J. Pathol. 143 (1993) 555-564
35. Prinjha R., Moore S.E., Vinson M., Blake S., Morrow R., Christie G., Michalovich D., Simmons D.L., and Walsh F.S. Inhibitor of neurite outgrowth in humans. Nature 403 (2000) 383-384
36. Reindl M., Khantane S., Ehling R., Schanda K., Lutterotti A., Brinkhoff C., Oertle T., Schwab M.E., Deisenhammer F., Berger T., and Bandtlow C.E. Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders. J. Neuroimmunol. 145 (2003) 139-147
37. Ruiz P.J., Garren H., Ruiz I.U., Hirschberg D.L., Nguyen L.V., Karpuj M.V., Cooper M.T., Mitchell D.J., Fathman C.G., and Steinman L. Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: modulation of T cell costimulation. J. Immunol. 162 (1999) 3336-3341
38. Satoh J., Onoue H., Arima K., and Yamamura T. Nogo-A and nogo receptor expression in demyelinating lesions of multiple sclerosis. J. Neuropathol. Exp. Neurol. 64 (2005) 129-138
39. Schluesener H.J., Sobel R.A., Linington C., and Weiner H.L. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 139 (1987) 4016-4021
40. Schwab M.E. Repairing the injured spinal cord. Science 295 (2002) 1029-1031
41. Schwab M.E., and Bartholdi D. Degeneration and regeneration of axons in the lesioned spinal cord. Physiol. Rev. 76 (1996) 319-370
42. Schwab M.E., and Caroni P. Oligodendrocytes and CNS myelin are nonpermissive substrates for neurite growth and fibroblast spreading in vitro. J. Neurosci. 8 (1988) 2381-2393
43. Scolding N.J., and Compston D.A. Oligodendrocyte-macrophage interactions in vitro triggered by specific antibodies. Immunology 72 (1991) 127-132
44. Silver P.B., Agarwal R.K., Su S.B., Suffia I., Grajewski R.S., Luger D., Chan C.C., Mahdi R.M., Nickerson J.M., and Caspi R.R. Hydrodynamic vaccination with DNA encoding an immunologically privileged retinal antigen protects from autoimmunity through induction of regulatory T cells. J. Immunol. 179 (2007) 5146-5158
45. Tuohy V.K., Lu Z.J., Sobel R.A., Laursen R.A., and Lees M.B. A synthetic peptide from myelin proteolipid protein induces experimental allergic encephalomyelitis. J. Immunol. 141 (1988) 1126-1130
46. Voeltz G.K., Prinz W.A., Shibata Y., Rist J.M., and Rapoport T.A. A class of membrane proteins shaping the tubular endoplasmic reticulum. Cell 124 (2006) 573-586
47. Wiessner C., Bareyre F.M., Allegrini P.R., Mir A.K., Frentzel S., Zurini M., Schnell L., Oertle T., and Schwab M.E. Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive rats. J. Cereb. Blood Flow. Metab. 23 (2003) 154-165
48. Xu G., Nie D.Y., Chen J.T., Wang C.Y., Yu F.G., Sun L., Luo X.G., Ahmed S., David S., and Xiao Z.C. Recombinant DNA vaccine encoding multiple domains related to inhibition of neurite outgrowth: a potential strategy for axonal regeneration. J. Neurochem. 91 (2004) 1018-1023
49. Zander H., Reineke U., Schneider-Mergener J., and Skerra A. Epitope mapping of the neuronal growth inhibitor Nogo-A for the Nogo receptor and the cognate monoclonal antibody IN-1 by means of the SPOT technique. J. Mol. Recognit. 20 (2007) 185-196